Comments on: Nasus Pharma to Present Positive Clinical Results from Recent studies of FMXIN002 (NS002) Intranasal Epinephrine at the 2025 AAAAI Annual Meeting https://www.nasuspharma.com/nasus-pharma-to-present-positive-clinical-results-from-recent-studies-of-fmxin002-ns002-intranasal-epinephrine-at-the-2025-aaaai-annual-meeting/?utm_source=rss&utm_medium=rss&utm_campaign=nasus-pharma-to-present-positive-clinical-results-from-recent-studies-of-fmxin002-ns002-intranasal-epinephrine-at-the-2025-aaaai-annual-meeting New frontier in Intranasal drug delivery Fri, 28 Feb 2025 13:20:06 +0000 hourly 1 https://wordpress.org/?v=6.8